• December 17, 2020

Do you have an innovative idea in a health related field? If so, NIH SBIR could be a viable way to obtain funding to take that idea or concept to the next level.

The NIH SBIR offers rolling deadlines each year. There are three rounds of due dates for the applications. The September deadline already passed, but January 5, 2021, and April 5, 2021 are coming up fast.

Can’t meet the April 2021 deadline? Don’t worry. A new solicitation will be issued sometime after April 6 with three deadlines folded in for 1) September, 2) January, and 3) April.

Notifications for awards are anticipated approximately 6 months later. The NIH SBIR Omnibus/Parent Grant Solicitations covers agencies including NIH, CDC, and FDA, Each FOA includes the option to apply for Phase I, Phase II, Direct to Phase II (NIH Only), Fast-Track (NIH only), and Phase IIB (NIH only).

There are 4 Funding Opportunity Announcements (FOAs) within the omnibus:

  • SBIR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement (PA-20-260)
  • STTR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement (PA-20-265)
  • SBIR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement (PA-20-262)
  • STTR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement (PA-20-261)

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Total funding support (direct costs, indirect costs, fee) normally may not exceed $256,580 for NIH SBIR Phase I awards and $1,710,531 for NIH SBIR Phase II awards. For specific topics, NIH may exceed these total award amounts.

Participating Agencies

The following agencies are participating in this NIH SBIR omnibus solicitation:

  • National Institutes of Health (NIH)
  • National Eye Institute (NEI)
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Human Genome Research Institute (NHGRI)
  • National Institute on Aging (NIA)
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Institute on Deafness and Other Communication Disorders (NIDCD)
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institute on Drug Abuse (NIDA)
  • National Institute of Environmental Health Sciences (NIEHS)
  • National Institute of General Medical Sciences (NIGMS)
  • National Institute of Mental Health (NIMH)
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • National Institute of Nursing Research (NINR)
  • National Institute on Minority Health and Health Disparities (NIMHD)
  • National Library of Medicine (NLM)
  • National Center for Complementary and Integrative Health (NCCIH)
  • National Center for Advancing Translational Sciences (NCATS)
  • Division of Program Coordination, Planning, and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

When responding to NIH SBIR or any FOA, it is recommended to reach out to the program officer prior to applying. This allows the applicant to ask any necessary questions or gain clarification about the application process.

To learn more about proposal preparation, please visit

More about NIH SBIR

Ready To Take the Next Step?

We assist our clients in locating, applying for, and evaluating the outcomes of non-dilutive grant funding. We believe non-dilutive funding is a crucial tool for mitigating investment risks, and we are dedicated to guiding our clients through the entire process—from identifying the most suitable opportunities to submitting and managing grant applications.